Biotronik Inc.

Biotronik Inc. is a foreign-owned, for-profit medical technology manufacturer headquartered in Lake Oswego, Oregon, that has been registered to receive federal contract awards since May 2001. The company specializes in the design and manufacture of advanced cardiovascular and endovascular medical devices, serving as a critical supplier to the U.S. federal healthcare system. Biotronik's product portfolio includes pacemakers, implantable cardioverter defibrillators (ICDs), coronary stents, cardiac resynchronization therapy devices, and associated leads and surgical implants. The company has established itself as a key vendor for federal agencies responsible for delivering healthcare to military personnel, veterans, and their families, leveraging its expertise in cardiac rhythm management and interventional cardiology to support mission-critical medical needs across the Department of Veterans Affairs and the Defense Health Agency.

Through its federal contract awards, Biotronik has delivered a diverse array of specialized cardiac medical devices and equipment to support surgical procedures and patient care at federal healthcare facilities. The company's primary deliverables include specific device models such as ACTICOR and RIVACOR pacemakers, PAPYRUS and ORSIRO MISSION coronary stents, INTICA and ILIVIA NEO implantable defibrillators, and associated pacemaker leads and batteries. Beyond implantable devices, Biotronik has also supplied specialized equipment including Zero-Gravity Suspended Radiation Protection Systems and cardiac monitoring devices such as the BIOMONITOR IIIM. The majority of contract awards have been issued by the Defense Health Agency and various Veterans Integrated Service Networks (VISNs 2, 4, 6, 7, 8, 9, 10, 12, 17, 20, and 23) within the Department of Veterans Affairs, with additional awards from the Air Education and Training Command and Air Combat Command. The contract awards have been predominantly firm fixed-price purchase orders and delivery orders, with individual contract values ranging from approximately $450 to $150,000, and no subcontractors or set-aside designations were identified across the award history. The company has performed work at multiple locations, with Lake Grove and Lake Oswego, Oregon, serving as primary performance sites, alongside federal facilities in California, Maryland, Texas, and other regions nationwide.

Biotronik Inc. holds two significant Indefinite Delivery Contracts and multiple Blanket Purchase Agreements that serve as the underlying vehicles for many of its routine procurement actions across federal agencies. The primary IDC is a single-award, $60.2 million Indefinite Delivery Contract with the Department of Veterans Affairs Headquarters, established on September 30, 2023, and extending through September 28, 2026, for the procurement of next-generation surgical implant devices to support the VA's healthcare delivery mission. A second significant IDC, valued at $7.49 million and awarded by the Defense Health Agency on September 20, 2024, extends through September 19, 2029, and covers cardiac surgical implants and supplies to support the military health system. Additionally, Biotronik maintains two Blanket Purchase Agreements: a single-award BPA with Veterans Integrated Service Network 12, established on March 25, 2022, with a ceiling value of $53,325 for ORSIRO MISSION drug-eluting stents and consignment services through September 30, 2023; and a single-award BPA with Veterans Integrated Service Network 23, effective March 1, 2021, through December 31, 2024, valued at $95,418, for consignment agreements covering non-biological implants including pacemakers, defibrillators, and other electrophysiology devices. These IDVs and BPAs have facilitated streamlined procurement across multiple VA regional networks and the Defense Health Agency, enabling federal healthcare providers to efficiently acquire critical cardiac technologies on an as-needed basis to support veteran and military personnel healthcare requirements.